Spatial predictors of immunotherapy response in triple-negative breast cancer

Breast cancer immunotherapy: Current biomarkers and the potential of in vitro assays - ScienceDirect

Frontiers Prognostic Value Of Various Immune Cells And, 53% OFF

Frontiers The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer

Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

IJMS, Free Full-Text

Frontiers Combination of multiple omics techniques for a personalized therapy or treatment selection

Cancers, Free Full-Text

Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer - ScienceDirect

Frontiers Multifactor assessment of ovarian cancer reveals immunologically interpretable molecular subtypes with distinct prognoses

Homologous recombination deficiency in triple-negative breast cancer: Multi-scale transcriptomics reveals distinct tumor microenvironments and limitations in predicting immunotherapy response - ScienceDirect

Mapping cancer biology in space: applications and perspectives on spatial omics for oncology, Molecular Cancer

SABCS 2021: Single-cell spatial analysis may help predict response to neoadjuvant immunotherapy in triple-negative breast cancer - ecancer

Research Group on Breast Cancer Biology – INCLIVA – Instituto de Investigación Sanitaria